Vitruvian Partners invests in IGEL, valuing it at more than $1 billion
Germany-based endpoint security software maker IGEL receives a strategic investment from Vitruvian Partners alongside existing investor TA Associates; stake not disclosed.
- Target
- IGEL
- Investor
- Vitruvian Partners
- Sponsor
- Vitruvian Partners, TA Associates
Vitruvian Partners has made a strategic investment in IGEL, a global software company, valuing the business at more than $1 billion, according to IGEL's announcement. Vitruvian joins existing investor TA Associates. The stake and investment amount were not disclosed, and the transaction is expected to close in the first quarter of 2027, subject to customary regulatory approvals.
IGEL was founded in 2001 and is headquartered in Germany, with U.S. offices in San Francisco and Fort Lauderdale. It sells the IGEL Adaptive Secure Endpoint Platform, spanning endpoint security, business continuity and disaster recovery, and operational technology. IGEL said its ARR grew more than 40% over the past year. TA first invested in the company in 2021.
Vitruvian partner Jack Alcock said IGEL's immutable endpoint products fit enterprises' Zero Trust strategies. William Blair advised TA and IGEL, and J.P. Morgan advised Vitruvian.
Background
- Business
- Global software company delivering the IGEL Adaptive Secure Endpoint Platform for secure access and endpoint resilience
- Deal type
- Investment
- Headquarters
- Germany
- Advisers
- William Blair financial adviser to TA Associates and IGEL
- J.P. Morgan financial adviser to Vitruvian Partners
Sources
- PR NewswireNov 18, 2026
- PR NewswireNov 18, 2026
- Unite.AINov 18, 2026
- Private Equity InternationalNov 18, 2026
- PR NewswireNov 19, 2026
- finance.yahoo.comNov 18, 2026
- PR NewswireNov 19, 2026
- Goodwin Procter LLPNov 19, 2026
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.
Follow coverage. Copy a feed link into your feed reader.